Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
1.070
-0.020 (-1.83%)
Jul 22, 2024, 10:08 AM EDT - Market open
Adial Pharmaceuticals Employees
As of December 31, 2023, Adial Pharmaceuticals had 7 total employees, including 4 full-time and 3 part-time employees. The number of employees decreased by 13 or -65.00% compared to the previous year.
Employees
7
Change (1Y)
-13
Growth (1Y)
-65.00%
Revenue / Employee
n/a
Profits / Employee
-$1,242,009
Market Cap
4.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Genetic Technologies | 60 |
Intelligent Bio Solutions | 51 |
Predictive Oncology | 35 |
Theriva Biologics | 22 |
Processa Pharmaceuticals | 13 |
Portage Biotech | 7 |
Artelo Biosciences | 6 |
Creative Medical Technology Holdings | 4 |
ADIL News
- 4 weeks ago - Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder - GlobeNewsWire
- 7 weeks ago - Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th - GlobeNewsWire
- 2 months ago - Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office - GlobeNewsWire
- 3 months ago - Adial Pharmaceuticals posts promising update on alcohol disorder drug - Invezz
- 3 months ago - Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder - GlobeNewsWire
- 3 months ago - Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds - GlobeNewsWire